HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.11
−7.20%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.12
From 52W high−93.48%
Volume681019.00
Market cap$5.50M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataSep 18, 2026
Open
$0.12
From 52W high
−93.48%
Volume
681019.00
Market cap
$5.50M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−7.1x
P/E (TTM)
—
RSI (14)
23.0
MomentumView details →
1D Return
−7.20%
YTD Return
−86.14%
SummaryUpdated Mar 1, 2026
Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) is a recently public company that went public on January 15, 2025. Founded by Lap Sun Wong on August 17, 2023, and headquartered in Hong Kong, the company operates in the specialized niche of pharmaceutical cross-border e-commerce supply chain services. Despite being a relatively new entity, the company has established itself as a facilitator of international pharmaceutical trade, particularly focusing on over-the-counter (OTC) medications and cross-border logistics solutions.
Similar companies
Latest newsMore news →
No recent news for HKPD.